Market revenue in 2023 | USD 6,924.9 million |
Market revenue in 2030 | USD 12,927.2 million |
Growth rate | 9.3% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Manufacturing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Development, Contract Manufacturing |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Recipharm, Siegfried Holding AG, Thermo Fisher Scientific Inc, Labcorp Drug Development, Jabil Inc, Syngene, IQVIA Holdings Inc, Almac Group, Ajinomoto Co Inc, Alcami, Vetter Pharma-Fertigung |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 77.99% in 2023. Horizon Databook has segmented the Brazil healthcare contract development and manufacturing organization market based on contract development, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Supportive government initiatives aimed at increasing investments in pharmaceutical & biotechnology industry by substituting imports with domestic products and encouraging partnerships between foreign & local companies are expected to increase the number of multinational pharmaceutical & medical device companies in Brazil.
This can help companies expand operations, launch new products, and undertake mergers & acquisitions. Such supportive initiatives are expected to fuel the market. For instance, in 2019, Telix Pharmaceuticals Limited appointed Grupo RPH for manufacturing and distributing TLX591-Cdx (68Ga-PSMA-11) cold kit in the country.
Brazil’s National Health Surveillance Agency has recently added a regulatory requirement that manufacturing services companies must attain a license as a medical manufacturing unit to maintain quality, safety, and performance parameters. This has made Brazil a lucrative market for various foreign manufacturers.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil healthcare contract development and manufacturing organization market , including forecasts for subscribers. This country databook contains high-level insights into Brazil healthcare contract development and manufacturing organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account